Edition:
United Kingdom

Corcept Therapeutics Inc (CORT.OQ)

CORT.OQ on NASDAQ Stock Exchange Capital Market

12.07USD
22 Oct 2018
Change (% chg)

-- (--)
Prev Close
$12.07
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
376,116
52-wk High
$25.92
52-wk Low
$11.55

Chart for

About

Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The Company is developing mifepristone, a compound that modulates the effects of cortisol by acting as a competitive... (more)

Overall

Beta: 2.07
Market Cap(Mil.): $2,309.91
Shares Outstanding(Mil.): 113.40
Dividend: --
Yield (%): --

Financials

  CORT.OQ Industry Sector
P/E (TTM): 101.94 30.90 33.64
EPS (TTM): 0.20 -- --
ROI: 50.69 14.75 14.27
ROE: 52.76 16.24 15.99

BRIEF-Corcept Therapeutics Reports Qtrly Revenue $57.7 Million

* CORCEPT THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

08 May 2018

Earnings vs. Estimates